Breath of Resilience: A Decade of Global Interventions for Pulmonary Tuberculosis (2015-2025)
DOI:
https://doi.org/10.55544/jrasb.5.1.3Keywords:
Tuberculosis, End TB Strategy, Drug-Resistant TB, Global HealthAbstract
Background: Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains the world’s second most deadly infectious disease. The WHO End TB Strategy (2015) sets ambitious goals for an 80% reduction in incidence and 90% reduction in deaths by 2030. This review assesses global progress and challenges during the 2015–2025 period.
Methods: This literature and data review synthesized information on global TB incidence, mortality, and key intervention strategies.
Results: The period saw a global decline in incidence and mortality, with high-burden countries like India achieving a notable 21% reduction in incidence since 2015. However, the disease remains a massive public health challenge, with 10.6 million new cases and 1.3 million deaths reported in 2022. Intervention efforts focused on developing shorter drug regimens (with improved success rates for drug-resistant TB, reaching 70–85%) and scaling up rapid molecular diagnostics. Crucial challenges include the persistent rise of drug-resistant TB (DR-TB), the need for simpler point-of-care tests, and the lack of a highly effective new vaccine to replace the BCG vaccine.
Conclusion: While global commitment and targeted interventions have demonstrated resilience and progress, the current pace is insufficient to meet the 2030 elimination targets. A sustained, strengthened global strategy requires the immediate development and deployment of innovative tools—including effective new vaccines and simplified diagnostics—alongside robust political and financial support to overcome the tenacity of DR-TB and ensure the global eradication of TB by 2035.
Downloads
References
Bindu Shajan Perappadan. Tuberculosis incidence in India declined by 21% from 2015 to 2024, The Hindu. 2025; 22 November 2025.
Pai M, Behr MA, Divangahi M, Menzies D, Dowdy D, Dheda K, Boehme CC, Ginsberg A, Swaminathan S, Spigelman M, Getahun H. Tuberculosis. Nature reviews. Disease primers. 2016; 2:16076.
World Health Organization. The End TB Strategy [Internet]. Who.int. 2015. Available from: https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/the-end-tb-strategy.
Lyon SM, Rossman MD. Pulmonary tuberculosis. Microbiol Spectr. 2017;5(1): 10.1128/microbiolspec.tnmi7-0032-2016.
Hunter RL. The pathogenesis of tuberculosis: the early infiltrate of post-primary (adult pulmonary) tuberculosis, a distinct disease entity. Front Immunol. 2018; 9:2108.
Bansal A, Yanamaladoddi VR, Sarvepalli SS, et al. Surviving pulmonary tuberculosis: navigating the long-term respiratory effects. Cureus. 2023;15(5): e38811.
Yang H, Ruan X, Li W, Xiong J, Zheng Y. Global, regional, and national burden of tuberculosis and attributable risk factors for 204 countries and territories, 1990–2021: a systematic analysis for the Global Burden of Diseases 2021 study. BMC Public Health. 2024;24(1):3111.
Fukunaga R, Glaziou P, Harris JB, Date A, Floyd K, Kasaeva T. Epidemiology of tuberculosis and progress toward meeting global targets worldwide, 2019. MMWR Morb Mortal Wkly Rep. 2021;70(12):427-430.
Nasiri MJ, Amiri M, Cheraghi M, et al. 15-year trends in efficacy and effectiveness of treatment outcomes in drug-resistant pulmonary TB. IJTLD Open. 2025;2(4):187-198.
Gai X, Chi H, Li R, Sun Y. Tuberculosis in infertility and in vitro fertilization-embryo transfer. Chin Med J (Engl). 2024;137(20):2404-2411.
Duan Z, Li D, Jia Q, Ji Y, Zhu Y, Wang G. The diagnostic potential of MPT63-derived HLA-A0201-restricted CD8+ T-cell epitopes for active pulmonary tuberculosis. Microbiol Immunol. 2015;59(12):705-15.
Ahn JG, Kim DS, Kim KH. Nosocomial exposure to active pulmonary tuberculosis in a neonatal intensive care unit. Am J Infect Control. 2015;43(12):1292-5.
Kanda R, Nagao T, Tho NV, Ogawa E, Murakami Y, Osawa M, et al. Factors affecting time to sputum culture conversion in adults with pulmonary tuberculosis: a historical cohort study without censored cases. PLoS One. 2015;10(11):e0142607.
Tripathy S, Kumar R, Singh SD. Prevalence of multidrug resistant pulmonary tuberculosis in North Bihar. J Clin Diagn Res. 2015;9(11):LC09-12.
Chuchottaworn C, Thanachartwet V, Sangsayunh P, Than TZ, Surabotsophon M, Desakorn V. Risk factors for multidrug-resistant tuberculosis among patients with pulmonary tuberculosis at the Central Chest Institute of Thailand. PLoS One. 2015;10(10):e0139986.
Kosgei RJ, Sitienei JK, Kipruto H, Komen B, Ng’ang’a L, Githui W, et al. Gender differences in treatment outcomes among 15–49-year-olds with smear-positive pulmonary tuberculosis in Kenya. Int J Tuberc Lung Dis. 2015;19(10):1176-81.
Oliveira CD, Melo AC, Oliveira LR, Froede EL, Camargos P. Control measures to trace ≤15-year-old contacts of index cases of active pulmonary tuberculosis. J Bras Pneumol. 2015;41(5):449-53.
Li C, He X, Li H, Wu X, Hu Z, Li J, et al. Discovery and verification of serum differential expression proteins for pulmonary tuberculosis. Tuberculosis (Edinb). 2015;95(5):547-54.
Togun TO, Egere U, Sillah AK, Ayorinde A, Mendy F, Otu J, et al. Contribution of Xpert MTB/RIF to the diagnosis of pulmonary tuberculosis among TB-exposed children in The Gambia. Int J Tuberc Lung Dis. 2015;19(9):1091-7.
Davidow AL, Katz D, Ghosh S, Blumberg HM, Tamhane A, Sevilla A, et al. Preventing infectious pulmonary tuberculosis among foreign-born residents of the United States. Am J Public Health. 2015;105(9):e81-8.
Li XX, Chen JX, Wang LX, Tian LG, Zhang YP, Dong SP, et al. Prevalence and risk factors of intestinal protozoan and helminth infections among pulmonary tuberculosis patients without HIV infection in rural China. Acta Trop. 2015; 149:19-26.
Jeyanathan M, Shao Z, Yu X, Harkness R, Jiang R, Li J, et al. AdHu5Ag85A respiratory mucosal boost immunization enhances protection against pulmonary tuberculosis in BCG-primed non-human primates. PLoS One. 2015;10(8):e0135009.
Prasad K, Basu A, Khana S, Wattal C. Pulmonary paragonimiasis mimicking tuberculosis. J Assoc Physicians India. 2015;63(8):82-3.
Sloan DJ, Mwandumba HC, Kamdolozi M, Shani D, Chisale B, Dutton J, et al. Vitamin D deficiency in Malawian adults with pulmonary tuberculosis: risk factors and treatment outcomes. Int J Tuberc Lung Dis. 2015;19(8):904-11.
Hernández-Pando R, Barrios-Payán J, Mata-Espinosa D, Marquina-Castillo B, Ramos-Espinosa O, Leyva R, et al. The role of high mobility group box 1 protein in the immunopathology of experimental pulmonary tuberculosis. PLoS One. 2015;10(7):e0133200.
Veerakumar AM, Sahu SK, Sarkar S, Kattimani S, Govindarajan S. Alcohol use disorders among pulmonary tuberculosis patients under RNTCP in urban Pondicherry, India. Indian J Tuberc. 2015;62(3):171-7.
Jayakumar A, Vittinghoff E, Segal MR, MacKenzie WR, Johnson JL, Gitta P, et al. Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis. Tuberculosis (Edinb). 2015;95(4):415-20.
Zheng R, Liu H, Song P, Feng Y, Li Z, Liu C, et al. Epstein-Barr virus-induced gene 3 polymorphisms and expression associated with susceptibility to pulmonary tuberculosis. Tuberculosis (Edinb). 2015;95(4):497-504.
Tavares e Castro A, Mendes M, Freitas S, Roxo PC. Diagnostic yield of sputum microbiological analysis for pulmonary tuberculosis over 10 years. Rev Port Pneumol. 2015;21(4):185-91.
Sloan DJ, Mwandumba HC, Garton NJ, Khoo SH, Butterworth AE, Allain TJ, et al. Pharmacodynamic modelling of bacillary elimination rates and detection of bacterial lipid bodies to predict outcomes in pulmonary tuberculosis treatment. Clin Infect Dis. 2015;61(1):1-8.
Damjanovic D, Khera A, Afkhami S, Hoang T, Ravi R, Zganiacz A, et al. Age at Mycobacterium bovis BCG priming and impact on mucosal AdHu5Ag85A vaccine boosting. PLoS One. 2015;10(6):e0131175.
Adane K, Ameni G, Bekele S, Abebe M, Aseffa A. Prevalence and drug resistance profile of Mycobacterium tuberculosis from pulmonary tuberculosis patients in East Gojjam zone, Ethiopia. BMC Public Health. 2015; 15:572.
Lai YJ, Liu EY, Wang LM, Suo JJ, Li ZJ, Li YP, et al. HIV-associated mortality during pulmonary tuberculosis treatment in China. Biomed Environ Sci. 2015;28(6):421-8.
Wu JT, Chiu CT, Wei YF, Lai YF. Safety and efficacy of fixed-dose combination vs. separate formulations for pulmonary tuberculosis. Clinics (Sao Paulo). 2015;70(6):429-34.
Lai R, Afkhami S, Haddadi S, Jeyanathan M, Xing Z. Mucosal immunity and novel TB vaccine strategies: route of immunisation determines T-cell homing. Eur Respir Rev. 2015;24(136):356-60.
Cardinale L, Volpicelli G, Onoscuri M, Veltri A. Response to: The imaging spectrum of pulmonary tuberculosis. Acta Radiol. 2015;56(6):NP35-6.
Oni T, Ehrlich R. Complicated silicotuberculosis in a South African gold miner: a case report. Am J Ind Med. 2015;58(6):697-701.
Munn MS, Duchin JS, Kay M, Pecha M, Thibault CS, Narita M. Risk factors for tuberculous infection after exposure in a homeless shelter. Int J Tuberc Lung Dis. 2015;19(5):570-5.
Manca S, Fois AG, Santoru L, Sotgiu G, Saderi L, Sotgiu MA, et al. Unusual clinical presentation of thoracic tuberculosis. Am J Case Rep. 2015;16:240-4.
Baker BJ, Holtom PD. Additional benefits of GeneXpert MTB/RIF assay for pulmonary tuberculosis evaluation among inpatients. Clin Infect Dis. 2015;60(8):1287-8.
Chiang CY, Bai KJ, Lin HH, Lee JJ, Enarson DA, Lee TI, et al. Influence of diabetes and glycemic control on pulmonary tuberculosis. PLoS One. 2015;10(3):e0121698.
Gu J, Tang SJ, Tan SY, Wu T, Zhang ZX, Wang LJ, et al. Efficacy of silibinin in preventing drug-induced liver injury: an open-label randomized trial. Int J Clin Exp Med. 2015;8(3):4320-7.
Kumarihamy KW, Ralapanawa DM, Jayalath WA. A rare complication of pulmonary tuberculosis: case report. BMC Res Notes. 2015; 8:39.
Walaza S, Tempia S, Dawood H, Variava E, Martinson NA, Moyes J, et al. Influenza virus infection increases risk of death in patients hospitalized with pulmonary tuberculosis, South Africa. BMC Infect Dis. 2015; 15:26.
Choby BA, Hunter P. Respiratory infections: pulmonary tuberculosis. FP Essent. 2015; 429:22-9.
Walaza S, Tempia S, Dawood H, Variava E, Martinson NA, Moyes J, et al. Influenza virus infection is associated with increased risk of death among patients hospitalized with confirmed pulmonary tuberculosis in South Africa, 2010–2011. BMC Infect Dis. 2015; 15:26.
Aiwale AS, Patel UA, Barvaliya MJ, Jha PR, Tripathi C. Isoniazid-induced convulsions at therapeutic dose in an alcoholic and smoker. Curr Drug Saf. 2015;10(1):94-5.
Guler SA, Bozkus F, Inci MF, Kokoglu OF, Ucmak H, Ozden S, et al. Evaluation of pulmonary and extrapulmonary tuberculosis in immunocompetent adults. Med Princ Pract. 2015;24(1):75-9.
Rea G, D'Amato M. The imaging spectrum of pulmonary tuberculosis: a critical appraisal. Acta Radiol. 2015;56(1):NP1-2.
Hongguang C, Min L, Shiwen J, He W, Liping M, Yufeng W, et al. Impact of diabetes on clinical presentation and treatment outcome of pulmonary tuberculosis in Beijing. Epidemiol Infect. 2015;143(1):150-6.
Peralta G, Barry P, Pascopella L. Use of nucleic acid amplification tests in tuberculosis patients in California, 2010–2013. Open Forum Infect Dis. 2016;3(4): ofw230.
Velayutham B, Nair D, Kannan T, Tripathy JP, Harries AD, Swaminathan S. Factors associated with sputum culture conversion in multidrug-resistant pulmonary tuberculosis. Int J Tuberc Lung Dis. 2016;20(12):1671-6.
Tirado Y, Puig A, Alvarez N, Borrero R, Aguilar A, Camacho F, et al. Mycobacterium smegmatis proteoliposome induces protection in a murine progressive pulmonary tuberculosis model. Tuberculosis (Edinb). 2016; 101:44-8.
Aldridge RW, Zenner D, White PJ, Williamson EJ, Muzyamba MC, Dhavan P, et al. Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study. Lancet. 2016;388(10059):2510-8.
Álvaro-Meca A, Díaz A, de Miguel Díez J, Resino R, Resino S. Environmental factors related to pulmonary tuberculosis in HIV-infected patients in the combined antiretroviral therapy era. PLoS One. 2016;11(11):e0165944.
Schumacher SG, van Smeden M, Dendukuri N, Joseph L, Nicol MP, Pai M, et al. Diagnostic test accuracy in childhood pulmonary tuberculosis: a Bayesian latent class analysis. Am J Epidemiol. 2016;184(9):690-700.
Liang Y, Wang Y, Li H, Zhang X, Xu L, Zhang Z, et al. Evaluation of a whole-blood chemiluminescent immunoassay of IFN-γ, IP-10, and MCP-1 for diagnosis of active pulmonary tuberculosis and tuberculous pleurisy. APMIS. 2016;124(10):856-64.
Mencarini P, Bellagamba R, Oliva A, Tommasi C, Mariano A, Camilli R, et al. Pulmonary tuberculosis followed by sarcoidosis in an HIV-infected patient: case report and simplified diagnostic flowchart. Respir Med Case Rep. 2016; 19:150-4.
Gopalan N, Chandrasekaran P, Swaminathan S, Tripathy S. Current trends and intricacies in management of HIV-associated pulmonary tuberculosis. AIDS Res Ther. 2016; 13:34.
Sara C, Elsa H, Baijayanti M, Lennartsdotter EM. Clinical correlates and drug resistance in HIV-infected and uninfected pulmonary tuberculosis patients in South India. World J AIDS. 2016;6(3):87-100.
Aryanpur M, Hosseini M, Masjedi MR, Mortaz E, Tabarsi P, Soori H, et al. A randomized controlled trial of smoking cessation methods in newly diagnosed pulmonary tuberculosis patients. BMC Infect Dis. 2016; 16:369.
Wang N, Ma Y, Liu YH, Xu B, Dong HY, Li Q, et al. Risk of treatment failure in drug-susceptible pulmonary tuberculosis in China. Biomed Environ Sci. 2016;29(8):612-7.
Mariappan VA, Sahu SK, Sarkar S, Kattimani S, Soundappan G. Smoked and smokeless tobacco use among pulmonary tuberculosis patients under RNTCP in urban Puducherry, India. Indian J Tuberc. 2016;63(3):158-66.
Mijiti P, Yuehua L, Feng X, Milligan P, Nsubuga P, Ghebremichael S, et al. Prevalence of pulmonary tuberculosis in western China, 2010–11. Lancet Glob Health. 2016;4(7):e485-94.
Ogbudebe CL, Izuogu S, Abu CE. Magnitude and treatment outcomes of pulmonary tuberculosis in a poor urban slum in Nigeria. Int J Mycobacteriol. 2016;5(2):205-10.
Tafess K, Mengistu B, Woldeyohannes D, Sisay S. Treatment outcome of smear-positive pulmonary tuberculosis in Afar, Ethiopia. Int J Mycobacteriol. 2016;5(2):164-9.
Sakai S, Kauffman KD, Sallin MA, Sharpe AH, Young HA, Ganusov VV, et al. CD4 T cell-derived IFN-γ plays a minimal role in controlling pulmonary M. tuberculosis and must be repressed by PD-1 to prevent lethal disease. PLoS Pathog. 2016;12(5):e1005667.
Gallardo CR, Rigau Comas D, Valderrama Rodríguez A, Gervilla J, Caylà J, Moreno V, et al. Fixed-dose combinations vs single-drug formulations for treating pulmonary tuberculosis. Cochrane Database Syst Rev. 2016;(5):CD009913.
Kehinde AO, Adebiyi EO, Salako AO, Daniel OJ, Aderibigbe SA, Oshi DC, et al. Drug resistance profiles in new and previously treated pulmonary tuberculosis patients in Nigeria. Afr J Med Med Sci. 2016;45(1):67-73.
Luetkemeyer AF, Firnhaber C, Kendall MA, Wu X, Mazurek GH, Benator DA, et al. Xpert MTB/RIF vs AFB smear and culture in suspected pulmonary TB. Clin Infect Dis. 2016;62(9):1081-8.
Lai CC, Hsieh YC, Yeh YP, Chien ST, Hsieh CY, Hsieh MJ, et al. A pulmonary tuberculosis outbreak in a long-term care facility. Epidemiol Infect. 2016;144(7):1455-62.
Ma J, Xia D, Hu J, Zhu M, Chen C, Tang S, et al. Predictive role of serum tumor markers in pulmonary tuberculosis. Iran J Public Health. 2016;45(4):435-40.
Kısa B, Sarımurat N, Koyman S, Yıldız N, Özkara Ş, Özkara A, et al. Tuberculosis screening and prophylaxis efficacy in contacts of pulmonary TB cases. Tuberk Toraks. 2016;64(1):27-33.
Ebonyi AO, Oguche S, Ejeliogu EU, Agbaji OO, Okpe ES, Ezeani I, et al. Pulmonary tuberculosis prevalence in newly diagnosed HIV-1 infected Nigerian children. Germs. 2016;6(1):21-8.
Wu Z, Guo J, Huang Y, Cai M, Peng Z, Wang F, et al. Diabetes mellitus in pulmonary tuberculosis in an aging Chinese population. J Diabetes Complications. 2016;30(2):237-41.
Adane K, Spigt M, Ferede S, Asmelash T, Abebe M, Dinant GJ. Half of pulmonary tuberculosis cases undiagnosed in Ethiopian prisons. PLoS One. 2016;11(2):e0149453.
Singer-Leshinsky S. Pulmonary tuberculosis: improving diagnosis and management. JAAPA. 2016;29(2):20-5.
Kim W, Lee KS, Kim HS, Jeong YJ, Kim EY, Choi YH, et al. CT and microbiologic follow-up in primary multidrug-resistant pulmonary tuberculosis. Acta Radiol. 2016;57(2):197-204.
Huang F, Zhang H, Lv Q, Liu J, Liu S, Wang Y, et al. Use of anti-tuberculosis drugs among newly diagnosed inpatients in China: a retrospective study. Infect Dis Poverty. 2016; 5:2.
Rodríguez DA, Verdonck K, Bissell K, Paredes C, Gotuzzo E, Seas C, et al. Monitoring delays in pulmonary tuberculosis diagnosis in Colombia. Rev Panam Salud Publica. 2016;39(1):12-8.
Aryanpur M, Masjedi MR, Mortaz E, Hosseini M, Tabarsi P, Soori H, et al. Intention to quit smoking among newly diagnosed pulmonary tuberculosis patients. Tanaffos. 2016;15(1):17-24.
Romaszko J, Siemaszko A, Bodzioch M, Buciński A, Doboszyńska A. Active case finding among homeless people to reduce pulmonary tuberculosis incidence. Adv Exp Med Biol. 2016;911: 67-76.
Lai CC, Hsieh YC, Yeh YP, Lee TF, Liu WL, Hsueh PR. A pulmonary tuberculosis outbreak in a long-term care facility. Epidemiol Infect. 2016;144(7):1455-62.
Wu Z, Guo J, Huang Y, Yang J, Chen X. Diabetes mellitus in patients with pulmonary tuberculosis in an aging population in Shanghai, China: prevalence, clinical characteristics and outcomes. J Diabetes Complications. 2016;30(2):237-41.
Kim W, Lee KS, Kim HS, Lee KY, Kim TS, Im JG. CT and microbiologic follow-up in primary multidrug-resistant pulmonary tuberculosis. Acta Radiol. 2016;57(2):197-204.
Field SK, Escalante P, Fisher DA, Ireland B, Irwin RS; CHEST Expert Cough Panel. Cough Due to TB and Other Chronic Infections: CHEST Guideline and Expert Panel Report. Chest. 2018;153(2):467-497. doi: 10.1016/j.chest.2017.11.018.
Kawatsu L, Uchimura K, Ohkado A, Kato S. Pulmonary tuberculosis and non-recent immigrants in Japan - some issues for post-entry interventions. Western Pac Surveill Response J. 2017;8(4):13-19. Published 2017 Dec 15. doi:10.5365/wpsar.2017.8.3.003.
Getnet F, Demissie M, Assefa N, Mengistie B, Worku A. Delay in diagnosis of pulmonary tuberculosis in low-and middle-income settings: systematic review and meta-analysis. BMC Pulm Med. 2017;17(1):202. Published 2017 Dec 13. doi:10.1186/s12890-017-0551-y.
Wang T, Zhao G, Rui YJ, Lu ZF, Mi JY. Left extensive infection in the forearm caused by whitlow infected by mycobacterium tuberculosis: A case report. Medicine (Baltimore). 2017;96(48): e8992. doi:10.1097/MD.0000000000008992
Khan PY, Crampin AC, Mzembe T, et al. Does antiretroviral treatment increase the infectiousness of smear-positive pulmonary tuberculosis. Int J Tuberc Lung Dis. 2017;21(11):1147-1154. doi:10.5588/ijtld.17.0162.
Yezli S, Zumla A, Yassin Y, et al. Undiagnosed Active Pulmonary Tuberculosis among Pilgrims during the 2015 Hajj Mass Gathering: A Prospective Cross-sectional Study. Am J Trop Med Hyg. 2017;97(5):1304-1309. doi:10.4269/ajtmh.17-0271
Rice JP, Seifert M, Moser KS, Rodwell TC. Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting. PLoS One. 2017;12(10):e0186139. Published 2017 Oct 9. doi: 10.1371/journal.pone.0186139.
Ahmed G, Saif MW. Pulmonary Tuberculosis Versus Recurrent Chemotherapy-Induced Pneumonitis: A Clinical Dilemma. Cureus. 2017;9(10):e1742. Published 2017 Oct 4. doi:10.7759/cureus.1742.
O'Connor DE, Frederix K, Saito S, et al. Pulmonary tuberculosis diagnostic practices among people living with the human immunodeficiency virus in Lesotho. Int J Tuberc Lung Dis. 2017;21(10):1133-1138. doi:10.5588/ijtld.17.0297
Jiang Y, Cao B, Ohmagari N, Wu AH, Liu YX, Guo LP. Comprehensive understanding of health-seeking behaviour among pulmonary tuberculosis patients in China. Int J Tuberc Lung Dis. 2017;21(10):1094-1099. doi:10.5588/ijtld.17.0227
Zheng X, Li T, Chen Y, et al. Genetic polymorphisms of the P2X7 gene associated with susceptibility to and prognosis of pulmonary tuberculosis. Infect Genet Evol. 2017; 53:24-29. doi: 10.1016/j.meegid.2017.05.003
Philips L, Visser J, Nel D, Blaauw R. The association between tuberculosis and the development of insulin resistance in adults with pulmonary tuberculosis in the Western sub-district of the Cape Metropole region, South Africa: a combined cross-sectional, cohort study. BMC Infect Dis. 2017;17(1):570. Published 2017 Aug 15. doi:10.1186/s12879-017-2657-5
Pallangyo P, Lyimo F, Bhalia S, et al. Bilateral multiple pulmonary artery aneurysms associated with cavitary pulmonary tuberculosis: a case report. J Med Case Rep. 2017;11(1):196. Published 2017 Jul 19. doi:10.1186/s13256-017-1360-x
Qi Z, Yang W, Wang YF. Epidemiological analysis of pulmonary tuberculosis in Heilongjiang province China from 2008 to 2015. Int J Mycobacteriol. 2017;6(3):264-267. doi: 10.4103/ijmy.ijmy_104_17.
Yunda LFI, Sepúlveda EVF, Herrera KCM, Moreno GC. Pulmonary tuberculosis in a Pediatric Reference Hospital in Bogotá, Colombia. Int J Mycobacteriol. 2017;6(3):258-263. doi: 10.4103/ijmy.ijmy_68_17.
Wang XM, Yin SH, Du J, et al. Risk factors for the treatment outcome of retreated pulmonary tuberculosis patients in China: an optimized prediction model. Epidemiol Infect. 2017;145(9):1805-1814. doi:10.1017/S0950268817000656.
Tan Y, Li Q, Wang Q, et al. Evaluation of the MTBDRplus 2.0 assay for the detection of multidrug resistance among persons with presumptive pulmonary TB in China. Sci Rep. 2017;7(1):3364. Published 2017 Jun 13. doi:10.1038/s41598-017-03473-7.
Tessema B, Moges F, Habte D, et al. Vitamin D deficiency among smear positive pulmonary tuberculosis patients and their tuberculosis negative household contacts in Northwest Ethiopia: a case-control study. Ann Clin Microbiol Antimicrob. 2017;16(1):36. Published 2017 May 11. doi:10.1186/s12941-017-0211-3.
Joo MH, Han MA, Park SM, Shin HH. Vitamin D Deficiency among Adults with History of Pulmonary Tuberculosis in Korea Based on a Nationwide Survey. Int J Environ Res Public Health. 2017;14(4):399. Published 2017 Apr 10. doi:10.3390/ijerph14040399.
Kayigire XA, Friedrich SO, van der Merwe L, Diacon AH. Acquisition of Rifampin Resistance in Pulmonary Tuberculosis. Antimicrob Agents Chemother. 2017;61(4):e02220-16. Published 2017 Mar 24. doi:10.1128/AAC.02220-16.
Said K, Hella J, Mhalu G, et al. Diagnostic delay and associated factors among patients with pulmonary tuberculosis in Dar es Salaam, Tanzania. Infect Dis Poverty. 2017;6(1):64. Published 2017 Mar 24. doi:10.1186/s40249-017-0276-4.
Getnet F, Hashi A, Mohamud S, Mowlid H, Klinkenberg E. Low contribution of health extension workers in identification of persons with presumptive pulmonary tuberculosis in Ethiopian Somali Region pastoralists. BMC Health Serv Res. 2017;17(1):193. Published 2017 Mar 11. doi:10.1186/s12913-017-2133-3.
Hermosilla S, You P, Aifah A, et al. Identifying risk factors associated with smear positivity of pulmonary tuberculosis in Kazakhstan. PLoS One. 2017;12(3):e0172942. Published 2017 Mar 1. doi: 10.1371/journal.pone.0172942.
Masjedi MR, Hosseini M, Aryanpur M, et al. The effects of smoking on treatment outcome in patients newly diagnosed with pulmonary tuberculosis. Int J Tuberc Lung Dis. 2017;21(3):351-356. doi:10.5588/ijtld.16.0513
Petersen E, Khamis F, Migliori GB, et al. De-isolation of patients with pulmonary tuberculosis after start of treatment - clear, unequivocal guidelines are missing. Int J Infect Dis. 2017; 56:34-38. doi: 10.1016/j.ijid.2017.01.029
Yoon YS, Jung JW, Jeon EJ, et al. The effect of diabetes control status on treatment response in pulmonary tuberculosis: a prospective study. Thorax. 2017;72(3):263-270. doi:10.1136/thoraxjnl-2015-207686.
Sudfeld CR, Mugusi F, Aboud S, Nagu TJ, Wang M, Fawzi WW. Efficacy of vitamin D3 supplementation in reducing incidence of pulmonary tuberculosis and mortality among HIV-infected Tanzanian adults initiating antiretroviral therapy: study protocol for a randomized controlled trial. Trials. 2017;18(1):66. Published 2017 Feb 10. doi:10.1186/s13063-017-1819-5.
Alfaraj SH, Al-Tawfiq JA, Altuwaijri TA, Memish ZA. Middle East Respiratory Syndrome Coronavirus and Pulmonary Tuberculosis Coinfection: Implications for Infection Control. Intervirology. 2017;60(1-2):53-55. doi:10.1159/000477908.
Adenager GS, Alemseged F, Asefa H, Gebremedhin AT. Factors Associated with Treatment Delay among Pulmonary Tuberculosis Patients in Public and Private Health Facilities in Addis Ababa, Ethiopia. Tuberc Res Treat. 2017: 5120841. doi:10.1155/2017/5120841.
Ochang EA, Emanghe UE, Ewa A, et al. Evaluation of pulmonary tuberculosis case detection improvement with the deployment of XpertMTB/Rif in the tuberculosis control program of cross River State, Nigeria. Int J Mycobacteriol. 2017;6(1):94-96. doi:10.4103/2212-5531.201890.
Mammen VG, Dangor Z, Moore DP, Izu A, Beylis N, Madhi SA. Hospitalization for Culture-confirmed Pulmonary Tuberculosis in the Era of Childhood Pneumococcal Conjugate Vaccine Immunization. Pediatr Infect Dis J. 2017;36(1):e14-e21. doi:10.1097/INF.0000000000001371
Ribeiro MG, Lima MCF, Franco MMJ, Paes AC, Listoni FJP, Silva DT, et al. Pre-multidrug-resistant Mycobacterium tuberculosis infection causing fatal enteric disease in a dog from a family with history of human tuberculosis. Transbound Emerg Dis. 2017;64(5):e4-7.
Zumla A, Otchere ID, Mensah GI, Bates M, Binladen J, Borrmann S, et al. Learning from epidemiological, clinical, and immunological studies on Mycobacterium africanum for improving understanding of host–pathogen interactions and for development of diagnostics, host-directed therapies, and vaccines for tuberculosis. Int J Infect Dis. 2017; 56:126-9.
Yoon YS, Jung JW, Jeon EJ, Seo JB, Yoo B, Lee CK, et al. Effect of diabetes control status on treatment response in pulmonary tuberculosis: a prospective study. Thorax. 2017;72(3):263-70.
Gordillo-Marroquín C, Gómez-Velasco A, Sánchez-Pérez HJ, Ancer-Rodríguez J, Flores-López CA, Jave-Suarez O, et al. Magnetic Nanoparticle-Based Biosensing Assay Quantitatively Enhances Acid-Fast Bacilli Count in Paucibacillary Pulmonary Tuberculosis. Biosensors (Basel). 2018;8(4):128.
Zhang W, Han C, Wang MS, He Y. Characteristics and factors associated with treatment delay in pleural tuberculosis. QJM. 2018;111(11):779-83.
Sagili KD, Muniyandi M, Nilgiriwala KS, Shringarpure KS, Satyanarayana S, Karyakram A, et al. Cost-effectiveness of GeneXpert and LED-FM for diagnosis of pulmonary tuberculosis: A systematic review. PLoS One. 2018;13(10):e0205233.
Roba AA, Dasa TT, Weldegebreal F, Yasin J, Abdalla A, Mohammed M, et al. Tuberculosis patients are physically challenged and socially isolated: A mixed methods case-control study of Health-Related Quality of Life in Eastern Ethiopia. PLoS One. 2018;13(10):e0204697.
Barry SE, Ellis M, Yang Y, Diefenbach EJ, Ma ZM, Jia Q, et al. Identification of a plasma microRNA profile in untreated pulmonary tuberculosis patients that is modulated by anti-mycobacterial therapy. J Infect. 2018;77(4):341-8.
Ahmad N, Ahuja SD, Akkerman OW, Alffenaar JC, Anderson LF, Baghaei P, et al. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet. 2018;392(10150):821-34.
Yaguchi D, Ichikawa M, Inoue N, Kobayashi A, Sakamoto A, Kondo T, et al. Sudden Death from Cardiopulmonary Arrest on Arrival of a Patient with Pulmonary Tuberculosis: A Case Diagnosed by Postmortem CT and Autopsy. J Forensic Sci. 2018;63(5):1582-6.
Du Preez K, Du Plessis L, O'Connell N, Hesseling AC. Burden, spectrum and outcomes of children with tuberculosis diagnosed at a district-level hospital in South Africa. Int J Tuberc Lung Dis. 2018;22(9):1037-43.
Chen L, Mei JZ, Chen XX, Wang Y, Zhang J, Li X, et al. Cost-effectiveness Analysis of Two Therapeutic Regimens for Newly Diagnosed Smear-negative Pulmonary Tuberculosis. Biomed Environ Sci. 2018;31(8):623-6.
Chandrasekaran P, Mave V, Thiruvengadam K, Gupte N, Shivakumar SVBY, Hannah LE, et al. Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden setting. PLoS One. 2018;13(8):e0199360.
Bai XJ, Li HM, Yang YR, Zhang JX, Liang Y, Wu XQ. Cytokine and soluble adhesion molecule profiles and biomarkers for treatment monitoring in Re-treated smear-positive patients with pulmonary tuberculosis. Cytokine. 2018; 108:9-16.
Zhao Y, Yang X, Zhang X, Zhao W, Yu L, Li J, et al. IP-10 and RANTES as biomarkers for pulmonary tuberculosis diagnosis and monitoring. Tuberculosis (Edinb). 2018;111:45-53.
Saqib SE, Ahmad MM, Amezcua-Prieto C, Virginia MR. Treatment Delay among Pulmonary Tuberculosis Patients within the Pakistan National Tuberculosis Control Program. Am J Trop Med Hyg. 2018;99(1):143-9.
Cheng CH, Yang CJ. Empiric anti-tuberculosis treatment is not always a right way in patients who had have poorly controlled diabetes mellitus and presented with pulmonary cavities over upper lungs in tuberculosis endemic countries. Epidemiol Infect. 2018;146(9):1205-6.
Nishiguchi S, Tomiyama S, Kitagawa I, Tokuda Y. Delayed isolation of smear-positive pulmonary tuberculosis patients in a Japanese acute care hospital. BMC Pulm Med. 2018;18(1):94.
Birungi FM, van Wyk B, Uwimana J, Ntaganira J, Graham SM. Xpert MTB/RIF assay did not improve diagnosis of pulmonary tuberculosis among child contacts in Rwanda. Pan Afr Med J. 2018; 30:39.
Poonawala H, Leekha S, Medina-Moreno S, Pegues DA, Sorkin JD, Gordin FM, et al. Use of a Single Xpert MTB/RIF Assay to Determine the Duration of Airborne Isolation in Hospitalized Patients with Suspected Pulmonary Tuberculosis. Infect Control Hosp Epidemiol. 2018;39(5):590-5.
Bhalla BB, Chadha VK, Gupta J, Kumar P, Jitendra R, Singh M, et al. Knowledge of private practitioners of Bangalore city in diagnosis, treatment of pulmonary tuberculosis and compliance with case notification. Indian J Tuberc. 2018;65(2):124-9.
Onyoh EF, Kuaban C, Lin HH. Pre-treatment loss to follow-up of pulmonary tuberculosis patients in two regions of Cameroon. Int J Tuberc Lung Dis. 2018;22(4):378-84.
Steigler P, Daniels NJ, McCulloch TR, Ryder BM, Sandford SK, Kirman JR. BCG vaccination drives accumulation and effector function of innate lymphoid cells in murine lungs. Immunol Cell Biol. 2018;96(4):379-89.
Ji YJ, Liang PP, Shen JY, Yin J, Li TT, Wang MS, et al. Risk factors affecting the mortality of HIV-infected patients with pulmonary tuberculosis in the cART era: a retrospective cohort study in China. Infect Dis Poverty. 2018;7(1):25.
Yan L, Kan X, Zhu L, Song Y, Ye T, Zhang L, et al. Short-course Regimen for Subsequent Treatment of Pulmonary Tuberculosis: A prospective, randomized, controlled multicenter clinical trial in China. Clin Ther. 2018;40(3):440-9.
Gong X, Li Y, Wang J, Li X, Li T, Qu Y, et al. Treatment adherence among sputum smear-positive pulmonary tuberculosis patients in Xinjiang, China: a prospective study. RSC Adv. 2018;8(16):8983-9.
Bonnett LJ, Ken-Dror G, Davies GR. Quality of reporting of outcomes in phase III studies of pulmonary tuberculosis: a systematic review. Trials. 2018;19(1):134.
Veesa KS, John KR, Moonan PK, Kaliappan SP, Manjunath K, Ragunathan P, et al. Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - Tamil Nadu, India. PLoS One. 2018;13(2): e0191591.
Williams E, Cheng AC, Lane GP, Guy SD. Delays in presentation and diagnosis of pulmonary tuberculosis: a retrospective study of a tertiary health service in Western Melbourne, 2011-2014. Intern Med J. 2018;48(2):184-93.
Wang X, Ma A, Han X, Wang T, Zhang Q, Zhao H, et al. T Cell Profile was Altered in Pulmonary Tuberculosis Patients with Type 2 Diabetes. Med Sci Monit. 2018; 24:636-42.
Acuña-Villaorduña C, Jones-López EC, Fregona G, Marques-Rodrigues P, Hadad DJ, Pereira Dantas O, et al. Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease. Eur Respir J. 2018;51(1):1701578.
Skowroński M, Halicka A, Barinow-Wojewódzki A. Pulmonary tuberculosis in a male with silicosis. Adv Respir Med. 2018;86(3):123-30.
Santos JA, Duarte R, Nunes C. Host factors associated to false negative and indeterminate results in an interferon-γ release assay in patients with active tuberculosis. Pulmonology. 2020;26 (6):353-62.
Hikone M, Ainoda Y, Sakamoto N, Ohnishi K. Clinical characteristics of elderly pulmonary tuberculosis in an acute-care general hospital in Tokyo, Japan: a 12-year retrospective study. J Infect Chemother. 2020;26(3):245-50.
Otero L, Battaglioli T, Ríos J, Caviedes L, Aiken J, Gilman RH, et al. Contact evaluation and isoniazid preventive therapy among close and household contacts of tuberculosis patients in Lima, Peru: an analysis of routine data. Trop Med Int Health. 2020;25(3):346-56.
Lopes A, Mougari F, Chopin D, Raskine L, Cambau E, Sougakoff W, et al. Prospective study comparing the conventional and same-day strategies to diagnose pulmonary tuberculosis. Med Mal Infect. 2020;50(1):36-42.
Banta JE, Ani C, Bvute KM, Lloren JIC, Darnell TA. Pulmonary vs extra-pulmonary tuberculosis hospitalizations in the US (1998–2014). J Infect Public Health. 2020;13(1):131-9.
Madjid TH, Ardhi I, Permadi W, Bahar E, Yulianti M, Yunus RE, et al. Correlation of clinical features, laboratory findings, and pelvic ultrasonography of pulmonary tuberculosis women with infertility. Int J Gen Med. 2019; 12:485-9.
Benjumea-Bedoya D, Marín DM, Robledo J, del Corral L, Arbelaez MP, Rueda ZV, et al. Risk of infection and disease progression in children exposed to tuberculosis at home, Colombia. Colomb Med (Cali). 2019;50(4):261-74.
Dolla CK, Padmapriyadarsini C, Thiruvengadam K, Bhavani PK, Sekar L, Ramesh Kumar S, et al. Age-specific prevalence of TB infection among household contacts of pulmonary TB: is it time for TB preventive therapy? Trans R Soc Trop Med Hyg. 2019;113(10):632-40.
Chancellor J, Lees J, Grimwade K, de Wet N, Borissenko L. Infectious pulmonary tuberculosis in a New Zealand cancer centre. N Z Med J. 2019;132(1503):46-52.
Marks GB, Nguyen NV, Nguyen PTB, Nguyen TA, Nguyen HB, Tran KH, et al. Community-wide screening for tuberculosis in a high-prevalence setting. N Engl J Med. 2019;381(14):1347-57.
Thiruvengadam S, Giudicatti L, Maghami S, Kulkarni V, Sreenivas A, Wares F, et al. Pulmonary tuberculosis: an analysis of isolation practices and clinical risk factors in a tertiary hospital. Indian J Tuberc. 2019;66(4):437-42.
Elzein FE, Alsherbeeni N, Mursi M, Al-Hedaithy M, Al-Hajoj S. Isolation and deisolation of patients admitted with presumptive pulmonary tuberculosis: can it be shortened? Saudi Med J. 2019;40(10):1008-12.
Holden IK, Lillebaek T, Seersholm N, Andersen PH, Wejse C, Johansen IS. Predictors for pulmonary tuberculosis treatment outcome in Denmark 2009–2014. Sci Rep. 2019; 9:12995.
Morikawa K, Misumi S, Fukuda T. A case of pulmonary tuberculosis with multiple nodules mimicking lung metastases. BJR Case Rep. 2019;5(3):20180124.
Polu GP, Mohammad Shaik J, Kota NMK, Karumanchi D, Allam US. Analysis of drug-resistance mutations in pulmonary Mycobacterium tuberculosis isolates in Southern coastal Andhra Pradesh, India. Braz J Infect Dis. 2019;23(5):281-90.
Wu CW, Wu YK, Lan CC, Lee CH, Hsu WH, Yu CJ, et al. Impact of nucleic acid amplification test on pulmonary tuberculosis notifications and treatments in Taiwan: a 7-year single-center cohort study. BMC Infect Dis. 2019; 19:726.
Patel KR, Patel A, Gadhiya NB. Risk factors for sputum-positive pulmonary tuberculosis retreatment cases and factors responsible for treatment outcome. J Assoc Physicians India. 2019;67(8):56-8.
Mthiyane T, Peter J, Allen J, Nyawo K, Meldau R, Theron G, et al. Urine lipoarabinomannan (LAM) and antimicrobial usage in seriously ill HIV-infected patients with sputum smear-negative pulmonary tuberculosis. J Thorac Dis. 2019;11(8):3505-14.
Kendall EA, Kamoga C, Kitonsa PJ, Nalutaaya A, Kaswabuli S, Ssempijja V, et al. Empiric treatment of pulmonary TB in the Xpert era: correspondence of sputum culture, Xpert MTB/RIF, and clinical diagnoses. PLoS One. 2019;14(7): e0220251.
Bogdanova E, Mariandyshev O, Hinderaker SG, Enarson D, Tomskikh I, Kourbatova E, et al. Mass screening for active case finding of pulmonary tuberculosis in the Russian Federation: how to save costs. Int J Tuberc Lung Dis. 2019;23(7):830-7.
Awoke N, Dulo B, Wudneh F. Total delay in treatment of tuberculosis and associated factors among new pulmonary TB patients in Gedeo Zone, Southern Ethiopia, 2017/18. Interdiscip Perspect Infect Dis. 2019: 2154240.
Li B, Zhang X, Guo J, Wang J, Pianduo B, Wei X, Yin T, Hu J. Prevalence of pulmonary tuberculosis in Tibet Autonomous Region, China, 2014. Int J Tuberc Lung Dis. 2019 Jun 1;23(6):735-740. doi: 10.5588/ijtld.18.0614. PMID: 31315707
Thiruvengadam S, Giudicatti L, Maghami S, Kulkarni V, Sreenivas A, Wares F, et al. Pulmonary tuberculosis: An analysis of isolation practices and clinical risk factors in a tertiary hospital. Indian J Tuberc. 2019;66(4):437-42.
Liu Q, Ji Y, Martinez L, Lu W, Wang L, Li J, et al. Combined tests with Xpert MTB/RIF assay with bronchoalveolar lavage fluid increasing the diagnostic performance of smear-negative pulmonary tuberculosis in Eastern China. Epidemiol Infect. 2020;149: e5.
Banerjee S, Severn M. Rapid and Simultaneous Tuberculosis and Antibiotic Susceptibility Testing for the Diagnosis of Pulmonary Tuberculosis and Rifampicin Resistance: A Review of Diagnostic Accuracy. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Dec 10.
Min J, Chung C, Jung SS, Park HK, Lee SS, Lee KM. Clinical profiles of subclinical disease among pulmonary tuberculosis patients: a prospective cohort study in South Korea. BMC Pulm Med. 2020;20(1):316.
Jain M, Jain M, Rodrigues E, Bhargava S. Using artificial intelligence for pulmonary TB prevention, diagnosis, and treatment. Indian J Tuberc. 2020;67(4S): S119-21.
Olvany JM, Sausville LN, White MJ, Tuck MK, Scriba TJ, Penn-Nicholson A, et al. CLEC4E (Mincle) genetic variation associates with pulmonary tuberculosis in Guinea-Bissau (West Africa). Infect Genet Evol. 2020; 85:104560.
Velayutham B, Jayabal L, Watson B, Chadha VK, Thiagesan R, Sreenivasan S, et al. Tuberculosis screening in household contacts of pulmonary tuberculosis patients in an urban setting. PLoS One. 2020;15(10):e0240594.
Islam MZ, Efa SS, Farjana S. Patient factors related to pre-treatment delay of pulmonary tuberculosis: A retrospective cohort study in Bangladesh. Indian J Tuberc. 2020;67(4):472-8.
Praveen V. Prevalence of LTBI among household contacts of sputum positive TB patients receiving DOTS chemotherapy. Indian J Tuberc. 2020;67(4):459-65.
Hu Y, Kang Y, Liu X, Cheng M, Dong J, Sun L, et al. Distinct lung microbial community states in patients with pulmonary tuberculosis. Sci China Life Sci. 2020;63(10):1522-33.
Xing Z, Ding W, Zhang S, Li Y, Zhu D, Wang L, et al. Machine Learning-Based Differentiation of Nontuberculous Mycobacteria Lung Disease and Pulmonary Tuberculosis Using CT Images. Biomed Res Int. 2020:6287545.
Katoto PDMC, Musole P, Maheshe G, Murhula AK, Kayembe JMN, Mafuta EM, et al. A miner with No left lung: Extensive pulmonary destruction in delayed effective Multi-Drug-Resistant Tuberculosis treatment. Respir Med Case Rep. 2020; 31:101234.
Lohiya A, Suliankatchi Abdulkader R, Rath RS, Kant S, Sogarwal R, Kumar R, et al. Prevalence and patterns of drug-resistant pulmonary tuberculosis in India-A systematic review and meta-analysis. J Glob Antimicrob Resist. 2020; 22:308-16.
Türkkani MH, Özdemir T, Özdilekcan Ç. Determination of related factors about diagnostic and treatment delays in patients with smear-positive pulmonary tuberculosis in Turkey. Turk J Med Sci. 2020;50(5):1371-9.
Cheng Q, Zhao G, Wang X, Zhang Z, Li Z, Wang L, et al. Nomogram for individualized prediction of incident multidrug-resistant tuberculosis after completing pulmonary tuberculosis treatment. Sci Rep. 2020;10(1):13730.
Patterson B, Koch A, Gessner S, Dinkele R, Gessner S, Abrahams C, et al. Bioaerosol sampling of patients with suspected pulmonary tuberculosis: a study protocol. BMC Infect Dis. 2020;20(1):587.
Sudfeld CR, Mugusi F, Muhihi A, Aboud S, Nagu TJ, Fawzi WW. Efficacy of vitamin D3 supplementation for the prevention of pulmonary tuberculosis and mortality in HIV: a randomised, double-blind, placebo-controlled trial. Lancet HIV. 2020;7(7):e463-71.
Das S, Mangold KA, Shah NS, Peterson LR, Thomson RB, Kaul KL. Performance and Utilization of a Laboratory-Developed Nucleic Acid Amplification Test (NAAT) for the Diagnosis of Pulmonary and Extrapulmonary Tuberculosis in a Low-Prevalence Area. Am J Clin Pathol. 2020;154(1):115-23.
Rodríguez-Márquez I, Montes F, Upegui LD, Ochoa J, Laniado C, Correa S, et al. Delays in diagnosing pulmonary tuberculosis within a context of medium incidence, Medellín, Colombia, 2017: operational research. BMC Public Health. 2020;20(1):757.
Deo S, Singh S, Jha N, Arinaminpathy N, Dewan P. Predicting the impact of patient and private provider behavior on diagnostic delay for pulmonary tuberculosis patients in India: A simulation modeling study. PLoS Med. 2020;17(5):e1003039.
Sinyavskaya AM, Shkurupy VA, Troitskiy AV, Kovner AM. Location of Pulmonary Mycobacteria Tuberculosis and Effectiveness of Various Dextrazide Compositions in Treatment of Mice with BCG-Induced Granulomatosis. Bull Exp Biol Med. 2020;169(1):63-6.
England JH, Byrne DW, Harris BD, Talbot TR. Use of airborne infection isolation in potential cases of pulmonary tuberculosis. Infect Control Hosp Epidemiol. 2020;41(5):505-9.
Hussain T, Tripathy SS, Das S, Gope RK, Sahu S, Rath S, et al. Prevalence, risk factors and health seeking behaviour of pulmonary tuberculosis in four tribal dominated districts of Odisha: Comparison with studies in other regions of India. PLoS One. 2020;15(4):e0227083.
Ji Y, Cao H, Liu Q, Li W, Li Z, Zhu D, et al. Screening for pulmonary tuberculosis in high-risk groups of diabetic patients. Int J Infect Dis. 2020; 93:84-9.
Elsafi SSMS, Nour BM, Abakar AD, Omer IH, Almugadam BS. Vitamin D level and it is association with the severity of pulmonary tuberculosis in patients attended to Kosti Teaching Hospital, Sudan. AIMS Microbiol. 2020;6(1):65-74.
Ben Jmaa M, Ben Ayed H, Koubaa M, Rekik K, Chakroun A, Mnif H, et al. The ongoing challenge of Pulmonary Tuberculosis in Southern Tunisia: A review of a 22-year period. Respir Med Res. 2020; 77:67-71.
Hikone M, Ainoda Y, Sakamoto N, Ohnishi K. Clinical characteristics of elderly pulmonary tuberculosis in an acute-care general hospital in Tokyo, Japan: A 12-year retrospective study. J Infect Chemother. 2020;26(3):245-50.
Ayiraveetil R, Sarkar S, Chinnakali P, Kulkarni V, Sreenivas A, Wares F, et al. Household food insecurity among patients with pulmonary tuberculosis and its associated factors in South India: a cross-sectional analysis. BMJ Open. 2020;10(2):e033798.
Wu Z, Rueda ZV, Li T, Li Y, Chen W, Wang L, et al. Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China. BMC Infect Dis. 2020;20(1):153.
Yang Q, Tong Y, Yin X, Mao L, Zhang X, Li S, et al. Delays in care seeking, diagnosis and treatment of patients with pulmonary tuberculosis in Hubei, China. Int Health. 2020;12(2):101-6.
Almohaya AM, Alotaibi NH, Alotaibi MS, Somily AM. Delayed inpatient diagnosis & isolation of active pulmonary tuberculosis patients, a large tertiary care academic hospital experience in Riyadh, Saudi. What are we missing? Saudi Med J. 2020;41(2):183-8.
Lopes A, Mougari F, Chopin D, Raskine L, Cambau E, Sougakoff W, et al. Prospective study comparing the conventional and same-day strategies to diagnose pulmonary tuberculosis. Med Mal Infect. 2020;50(1):36-42.
Banta JE, Ani C, Bvute KM, Lloren JIC, Darnell TA. Pulmonary vs. extra-pulmonary tuberculosis hospitalizations in the US [1998-2014]. J Infect Public Health. 2020;13(1):131-9.
Afum T, Asare P, Asante-Poku A, Forson A, Laryea C, Osei-Wusu S, et al. Diagnosis of tuberculosis among COVID-19 suspected cases in Ghana. PLoS One. 2021;16(12):e0261849.
Kumar P. A Perspective on the Success and Failure of BCG. Front Immunol. 2021; 12:778028.
Bamidele J, Oguntayo D, Gbadebo A, Odukoya O, Ogunbiyi O, Adebiyi O, et al. Tuberculosis/HIV Prevalence and Treatment Success among Children Receiving Care in Two Tertiary Health Facilities within Ogun State, Nigeria. Niger Med J. 2021;62(1):33-9.
Du J, Li Q, Liu M, Li J, Liu E, Gao J, et al. Distinguishing Relapse from Reinfection With Whole-Genome Sequencing in Recurrent Pulmonary Tuberculosis: A Retrospective Cohort Study in Beijing, China. Front Microbiol. 2021; 12:754352.
Song WM, Guo J, Xu TT, Li Q, Liu J, Wang J, et al. Association between body mass index and newly diagnosed drug-resistant pulmonary tuberculosis in Shandong, China from 2004 to 2019. BMC Pulm Med. 2021;21(1):399.
Cegielski JP, Chan PC, Lan Z, Udwadia ZF, Viiklepp P, Yim JJ, et al. Aminoglycosides and Capreomycin in the Treatment of Multidrug-resistant Tuberculosis: Individual Patient Data Meta-analysis of 12 030 Patients From 25 Countries, 2009-2016. Clin Infect Dis. 2021;73(11):e3929-e3936.
Lu P, Lu F, Liu Q, Liu Y, Wang L, Li L, et al. High rate of transmission in a pulmonary tuberculosis outbreak in a junior high school in China, 2020. IJID Reg. 2021; 1:117-23.
Song Q, Bian Q, Liang T, Zhang Y, Zhang K. Identification of immune-related genes and susceptible population of pulmonary tuberculosis by constructing TF-miRNA-mRNA regulatory network. Tuberculosis (Edinb). 2021; 131:102139.
Nagu TJ, Mboka MA, Nkrumbih ZF, Mwashembe R, Mhimbira FA, Gagneux S, et al. Clinical and Imaging Features of Adults with Recurrent Pulmonary Tuberculosis - A Prospective Case-Controlled Study. Int J Infect Dis. 2021;113 Suppl 1:S33-S39.
Wang Y, Shang X, Wang L, Zhang Y, Zhao X, Li J, et al. Clinical characteristics and chest computed tomography findings related to the infectivity of pulmonary tuberculosis. BMC Infect Dis. 2021;21(1):1197.
Ngah V, Maud P, Baines N, Mash R, Oni T. Respiratory presentations to acute services at a tertiary hospital in South Africa. S Afr Med J. 2021;111(11):1104-9.
Micheni LN, Kassaza K, Kinyi H, Ntulume I, Bazira J. Rifampicin and isoniazid drug resistance among patients diagnosed with pulmonary tuberculosis in southwestern Uganda. PLoS One. 2021;16(10):e0259221.
Shi W, Hu Y, Ning Z, Wang Y, Yang J, Xiong H, et al. Alterations of gut microbiota in patients with active pulmonary tuberculosis in China: a pilot study. Int J Infect Dis. 2021; 111:313-21.
Solomos Z, Botsi C, Georgakopoulou T, Lytras T, Tsiodras S, Puchner KP. Active case finding of pulmonary TB in a European refugee camp: lessons learnt from Oinofyta hosting site in Greece. Trop Med Int Health. 2021;26(9):1068-74.
Sinnathamby A, Ang S, Bagdasarian N, Chan HC, Chan SM. Low uptake of isoniazid window prophylaxis in patients exposed to a health-care worker with pulmonary tuberculosis in a paediatric ward. J Paediatr Child Health. 2021;57(9):1408-13.
Kalaycı Yüksek F, Kığ C, Ortaköylü G, Uzun M. Association between active pulmonary tuberculosis and circulating microRNAs: a preliminary study from Turkey. Turk J Med Sci. 2021;51(4):1894-904.
Kan T, Komiya K, Yamasue M, Kadota JI, Takahashi K, Yasuda H, et al. Comparison of chest computed tomography features between pulmonary tuberculosis patients with culture-positive and culture-negative sputum for non-mycobacteria: A retrospective observational study. Medicine (Baltimore). 2021;100(31):e26897.
Han J, Yuan L, Li J, Liang C, Zhang D, Mei Z. Transbronchial tuberculosis cavity plugging therapy for pulmonary tuberculosis. J Int Med Res. 2021;49(8):3000605211035889.
Zürcher K, Reichmuth ML, Ballif M, Loiseau C, Borrell S, Reinhard M, et al. Mortality from drug-resistant tuberculosis in high-burden countries comparing routine drug susceptibility testing with whole-genome sequencing: a multicentre cohort study. Lancet Microbe. 2021;2(7):e320-e330.
Boardman NJ, Moore T, Freiman J, Creighton C, Shah L, Narita M, et al. Pulmonary Tuberculosis Disease Among Immigrant Detainees: Rapid Disease Detection, High Prevalence of Asymptomatic Disease, and Implications for Tuberculosis Prevention. Clin Infect Dis. 2021;73(1):115-20.
Vonasek B, Ness T, Takwoingi Y, Kay AW, van Wyk SS, Ouellette L, et al. Screening tests for active pulmonary tuberculosis in children. Cochrane Database Syst Rev. 2021;6(6):CD013693.
Sahiratmadja E, Rini IA, Penggoam S, Charles A, Maskoen AM, Parwati I. Acetylator Status Among Newly Diagnosed and Recurrent Tuberculosis Patients from Kupang, Eastern Part of Indonesia. Pharmgenomics Pers Med. 2021; 14:737-44.
Notarfrancesco M, Castelnuovo B, Kaelin M, Fehr J, Sekaggya-Wiltshire C. 'Out of sight, out of mind?' A follow-up on HIV-infected patients with drug-resistant pulmonary tuberculosis in Uganda: A case series. SAGE Open Med Case Rep. 2021; 9:2050313X211019790.
Aceves-Sánchez MJ, Flores-Valdez MA, Pedroza-Roldán C, Gutiérrez-Pabello JA, Vega-Domínguez PJ, Báez-Saldaña R, et al. Vaccination with BCGΔBCG1419c protects against pulmonary and extrapulmonary TB and is safer than BCG. Sci Rep. 2021;11(1):12417.
Galamay LC, Chee CBE, Khin Mar KW, Lau BQ, Wang YT. Smear-positive pulmonary tuberculosis patients with previously abnormal chest radiographs: missed opportunities for early diagnosis. Singapore Med J. 2021;62(6):296-9.
Veluthat C, Venkatnarayan K, Padaki P, Krishnaswamy UM. Case of melioidosis misdiagnosed as pulmonary tuberculosis. BMJ Case Rep. 2021;14(5):e242499.
Kabir S, Parash MTH, Emran NA, Hossain ABMT, Shimmi SC. Diagnostic challenges and Gene-Xpert utility in detecting Mycobacterium tuberculosis among suspected cases of Pulmonary tuberculosis. PLoS One. 2021;16(5):e0251858.
Jarsberg LG, Kedia K, Wendler J, Ridenhour T, Weiner M, Savic RM. Nutritional markers and proteome in patients undergoing treatment for pulmonary tuberculosis differ by geographic region. PLoS One. 2021;16(5):e0250586.
Ştefanescu S, Cocoş R, Turcu-Stiolica A, Bogdan M, Matei M, Plesca CE, et al. Evaluation of prognostic significance of hematological profiles after the intensive phase treatment in pulmonary tuberculosis patients from Romania. PLoS One. 2021;16(4):e0249301.
Sun X, Liu K, Wang X, Zhang T, Li X, Zhao Y. Diagnostic value of microRNA 125b in peripheral blood mononuclear cells for pulmonary tuberculosis. Mol Med Rep. 2021;23(4):249.
Li SJ, Li YF, Song WM, Zhang Y, Li X, Wang F, et al. Population aging and trends of pulmonary tuberculosis incidence in the elderly. BMC Infect Dis. 2021;21(1):302.
Yousif K, Ei Maki M, Babikir RK, Abuaisha H. The effect of an educational intervention on awareness of various aspects of pulmonary tuberculosis in patients with the disease. East Mediterr Health J. 2021;27(3):287-92.
Bothamley GH. Male Sex Bias in Immune Biomarkers for Tuberculosis. Front Immunol. 2021; 12:640903.
Charoensakulchai S, Lertpheantum C, Aksornpusitpong C, Watthanachai P, Tangsujaritvijit V. Six-year trend and risk factors of unsuccessful pulmonary tuberculosis treatment outcomes in Thai Community Hospital. BMC Res Notes. 2021;14(1):89.
Gersh JK, Barnabas RV, Matemo D, Pintye J, Drake AL, Otieno G, et al. Pulmonary tuberculosis screening in anti-retroviral treated adults living with HIV in Kenya. BMC Infect Dis. 2021;21(1):218.
Kamejima S, Yamamoto I, Kobayashi A, Hasegawa M, Tatsumi S, Yamazaki Y, et al. Hypercalcemia caused by comorbid parathyroid adenoma and pulmonary tuberculosis. CEN Case Rep. 2021;10(1):1-5.
Ramakrishnan J, Sarkar S, Chinnakali P, Kulkarni V, Sreenivas A, Wares F, et al. Risk factors for death during treatment in pulmonary tuberculosis patients in South India: A cohort study. Indian J Tuberc. 2021;68(1):32-9.
Vasantham V, Singh G, Jahan A, Arava S, Ray R, Mathur S, et al. Codetection of pulmonary tuberculosis and toxoplasmosis in a pediatric bronchoalveolar lavage specimen: A cytologist's assistance to clinical management. Diagn Cytopathol. 2021;49(1):E20-E23.
Singla R, Raghu B, Gupta A, Caminero JA, Kaur H, Solanki R. Risk factors for early mortality in patients with pulmonary tuberculosis admitted to the emergency room
Galamay LC, Chee CBE, Khin Mar KW, Lau BQ, Wang YT. Smear-positive pulmonary tuberculosis patients with previously abnormal chest radiographs: missed opportunities for early diagnosis. Singapore Med J. 2021;62(6):296-9.
Kamejima S, Yamamoto I, Kobayashi A, Hasegawa M, Tatsumi S, Yamazaki Y, et al. Hypercalcemia caused by comorbid parathyroid adenoma and pulmonary tuberculosis. CEN Case Rep. 2021;10(1):1-5.
Ramakrishnan J, Sarkar S, Chinnakali P, Kulkarni V, Sreenivas A, Wares F, et al. Risk factors for death during treatment in pulmonary tuberculosis patients in South India: A cohort study. Indian J Tuberc. 2021;68(1):32-9.
Vasantham V, Singh G, Jahan A, Arava S, Ray R, Mathur S, et al. Codetection of pulmonary tuberculosis and toxoplasmosis in a pediatric bronchoalveolar lavage specimen: A cytologist's assistance to clinical management. Diagn Cytopathol. 2021;49(1):E20-3.
Singla R, Raghu B, Gupta A, Caminero JA, Kaur H, Solanki R. Risk factors for early mortality in patients with pulmonary tuberculosis admitted to the emergency room. Pulmonology. 2021;27(1):35-42.
Jaganath D, Beaudry J, Salazar-Austin N. Tuberculosis in Children. Infect Dis Clin North Am. 2022;36(1):49-71.
Martinez L, Cords O, Liu Q, Acuna-Villaorduna C, Bonnet M, Fox GJ, et al. Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis. Lancet Glob Health. 2022;10(9):e1307-16.
Zhang G, Yu Y, Zhang W, Shang J, Chen S, Pang X, et al. Influence of COVID-19 for delaying the diagnosis and treatment of pulmonary tuberculosis-Tianjin, China. Front Public Health. 2022; 10:937844.
Ruan QL, Yang QL, Sun F, Liu W, Shen YJ, Wu J, et al. Recurrent pulmonary tuberculosis after treatment success: a population-based retrospective study in China. Clin Microbiol Infect. 2022;28(5):684-9.
Mok J, Lee M, Kim DK, Kim JS, Jhun BW, Jo KW, et al. 9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South Korea. Lancet. 2022;400(10362):1522-30.
Feng JY, Lin CJ, Wang JY, Chien ST, Lin CB, Huang WC, et al. Nucleic acid amplification tests reduce delayed diagnosis and misdiagnosis of pulmonary tuberculosis. Sci Rep. 2022;12(1):12064.
An H, Liu X, Wang T, Liu L, Yan M, Xu J, et al. Endobronchial Valve Treatment of Tuberculous Cavities in Patients with Multidrug-Resistant Pulmonary Tuberculosis: A Randomized Clinical Study. Pathogens. 2022;11(8):899.
Bargaje M, Bharaswadkar S, Lohidasan S, Panda BK. Plasma drug concentrations of 4-drug fixed-dose combination regimen and its efficacy for treatment of pulmonary tuberculosis under National Tuberculosis Elimination Programme: A prospective pilot study. Indian J Tuberc. 2022;69(3):311-9.
Hulya S, Naz I, Karadeniz G, Erkan S. Clinical effects of TB sequelae in patients with COPD. Int J Tuberc Lung Dis. 2022;26(4):363-8.
Tomeny EM, Nightingale R, Chinoko B, Nikolaidis GF, Madan JJ, Worrall E, et al. TB morbidity estimates overlook the contribution of post-TB disability: evidence from urban Malawi. BMJ Glob Health. 2022;7(5): e007643.
Sobral L, Arriaga MB, Souza AB, Araújo-Pereira M, Barreto-Duarte B, Sales C, et al. Determinants of losses in the tuberculosis infection cascade of care among children and adolescent contacts of pulmonary tuberculosis cases: A Brazilian multi-centre longitudinal study. Lancet Reg Health Am. 2022; 15:100358.
Wang S, Yang L, Hu H, Lv L, Ji Z, Zhao Y, et al. Characteristic gut microbiota and metabolic changes in patients with pulmonary tuberculosis. Microb Biotechnol. 2022;15(1):262-75.
Ren Y, Chen B, Zhao J, Tan X, Chen X, Zhou L, et al. Trends of Rifampicin Resistance in Patients with Pulmonary Tuberculosis: A Longitudinal Analysis Based on Drug Resistance Screening in Eastern China Between 2015 and 2019. Infect Drug Resist. 2022; 15:7707-17.
Ma L, Chen X, Gao M. Analysis on the Risk Factors of Malnutrition in Type 2 Diabetes Mellitus Patients with Pulmonary Tuberculosis. Infect Drug Resist. 2022; 15:7555-64.
Shukla A, Bromage S, Dholakia Y, Hemler EC, Dev P, Govekar L, et al. Case-control study of vitamin D status and adult multidrug-resistant pulmonary TB. Int J Tuberc Lung Dis. 2022;26(9):826-34.
Xu F, Bian K, Wang S, Yao F, Chen J, Cao Y, et al. B and T lymphocyte attenuator as a C-reactive protein and IgA associated auxiliary diagnostic marker for pulmonary tuberculosis: a case-control study. Ann Transl Med. 2022;10(24):1370.
An HR, Bai XJ, Liang JQ, Wang T, Wang ZY, Xue Y, et al. The relationship between absolute counts of lymphocyte subsets and clinical features in patients with pulmonary tuberculosis. Clin Respir J. 2022;16(5):369-79.
Ma L, Gu JX, Li Q, Li YH, Wang DD, He J, et al. Current situation on drug resistance and influencing factors of multidrug-resistance in newly treated pulmonary tuberculosis patients in Gansu province. Zhonghua Liu Xing Bing Xue Za Zhi. 2022;43(7):1093-8.
Li J, Parrott S, Keding A, Dogar O, Gabe R, Marshall AM, et al. Cost-utility of cytisine for smoking cessation over and above behavioural support in people with newly diagnosed pulmonary tuberculosis: an economic evaluation of a multicentre randomised controlled trial. BMJ Open. 2022;12(8):e049644.
Bilmumad B, Liabsuetrakul T, Ngamtrairai N, Chongsuvivatwong V. Pulmonary tuberculosis among prisoners in Southern Thailand: prevalence and its association with imprisonment status. Int J Prison Health. 2022;18(3):233-44.
Bargaje M, Bharaswadkar S, Lohidasan S, Panda BK. Plasma drug concentrations of 4-drug fixed-dose combination regimen and its efficacy for treatment of pulmonary tuberculosis under National Tuberculosis Elimination Programme: A prospective pilot study. Indian J Tuberc. 2022;69(3):311-319.
Ruan QL, Yang QL, Sun F, Zhang S, Liu J, Liu Y, et al. Recurrent pulmonary tuberculosis after treatment success: a population-based retrospective study in China. Clin Microbiol Infect. 2022;28(5):684-9.
Ma J, Huang M, Wang SH, Tan QM, Zhang LS. Undiagnosed pleural effusion treated with traditional Chinese medicine: A case report. Explore (NY). 2022;18(3):362-5.
Kim JS, Kim YH, Lee SH, Kim HR, Lee MK, Park JS, et al. Early Bactericidal Activity of Delpazolid (LCB01-0371) in Patients with Pulmonary Tuberculosis. Antimicrob Agents Chemother. 2022;66(2):e0168421.
Torpiano P, Holwill S, Pace D. Mesangiocapillary glomerulonephritis complicating pulmonary tuberculosis. CEN Case Rep. 2022;11(1):17-21.
Wang S, Yang L, Hu H, Bai L, Wang J, Liu X, et al. Characteristic gut microbiota and metabolic changes in patients with pulmonary tuberculosis. Microb Biotechnol. 2022;15(1):262-75.
Mahajan P, Soundappan K, Singla N, et al. Test and Treat Model for Tuberculosis Preventive Treatment among Household Contacts of Pulmonary Tuberculosis Patients in Selected Districts of Maharashtra: A Mixed-Methods Study on Care Cascade, Timeliness, and Early Implementation Challenges. Trop Med Infect Dis. 2023;9(1):7.
Li G, Feng Z, Song H, Wang Y, Zhu L, Li Y. Long non-coding RNA expression in PBMCs of patients with active pulmonary tuberculosis. Front Microbiol. 2023; 14:1257267.
Goussard P, Eber E, Venkatakrishna S, et al. Interventional bronchoscopy in pediatric pulmonary tuberculosis. Expert Rev Respir Med. 2023;17(12):1159-1175.
Deng F, Xu P, Miao J, Jin C, Tu H, Zhang J. Pulmonary tuberculosis biomarker miR-215-5p inhibits autophagosome-lysosome fusion in macrophages. Tuberculosis (Edinb). 2023; 143:102422.
Gray AT, Macpherson L, Carlin F, et al. Treatment for radiographically active, sputum culture-negative pulmonary tuberculosis: A systematic review and meta-analysis. PLoS One. 2023;18(11):e0293535.
Yang J, Ye W, Zhang C, et al. Accuracy of Nanopore Sequencing as a Diagnostic Assay for Pulmonary Tuberculosis versus Smear, Culture and Xpert MTB/RIF: A Head-to-Head Comparison. Trop Med Infect Dis. 2023;8(9):441.
Kalva J, Babu SP, Narasimhan PB, et al. Predictors of weight loss during the intensive phase of tuberculosis treatment in patients with drug-susceptible pulmonary tuberculosis in South India. J Public Health (Oxf). 2023;45(3):545-552.
Bhargava A, Bhargava M, Meher A, et al. Nutritional supplementation to prevent tuberculosis incidence in household contacts of patients with pulmonary tuberculosis in India (RATIONS): a field-based, open-label, cluster-randomised, controlled trial. Lancet. 2023;402(10402):627-640.
Zhang Y, Zhan B, Hao X, et al. Factors associated with diagnostic delay of pulmonary tuberculosis among children and adolescents in Quzhou, China: results from the surveillance data 2011-2021. BMC Infect Dis. 2023;23(1):541.
Meregildo-Rodriguez ED, Asmat-Rubio MG, Vásquez-Tirado GA. Droplet digital PCR vs. quantitative real time-PCR for diagnosis of pulmonary and extrapulmonary tuberculosis: systematic review and meta-analysis. Front Med (Lausanne). 2023; 10:1248842.
Moideen K, Nathella PK, Madabushi S, et al. Plasma Vitamin D levels in correlation with circulatory proteins could be a potential biomarker tool for pulmonary tuberculosis and treatment monitoring. Cytokine. 2023; 168:156238.
Zhang M, Lu Y, Zhu Y, et al. Whole-Genome Sequencing to Predict Mycobacterium tuberculosis Drug Resistance: A Retrospective Observational Study in Eastern China. Antibiotics (Basel). 2023;12(8):1257.
Pelosi U, Pintus R, Savasta S, Fanos V. Pulmonary Tuberculosis in Children: A Forgotten Disease? Microorganisms. 2023;11(7):1722.
Okuma T, Mizushima R, Takeda Y, et al. Pulmonary miliary sarcoidosis masquerading the reactivation of tuberculosis 30 years later. Clin Case Rep. 2023;11(6):e7624.
Kadyrov M, Thekkur P, Geliukh E, et al. Contact Tracing and Tuberculosis Preventive Therapy for Household Child Contacts of Pulmonary Tuberculosis Patients in the Kyrgyz Republic: How Well Are We Doing? Trop Med Infect Dis. 2023;8(7):332.
Jember T, Hailu G, Wassie GT. Assessment of Family Tuberculosis Contact Screening Practice and its Associated Factors Among Pulmonary Tuberculosis Positive Patients in South Wollo Zone, Amhara Region, Ethiopia. Int J Public Health. 2023; 68:1605815.
Yezli S, Yassin Y, Mushi A, et al. Undiagnosed and missed active pulmonary tuberculosis during mass gatherings: a prospective cross-sectional study from the Hajj pilgrimage. Eur J Clin Microbiol Infect Dis. 2023;42(6):727-740.
Weldemhret L. Burden of pulmonary tuberculosis and challenges related to tuberculosis detection in Ethiopia. J Infect Dev Ctries. 2023;17(5):578-582.
Charii H, Tahri S, Boudouh A, Kouismi H, Bourkadi JE. Anaphylactic Shock After First-Line Treatment With Antituberculosis Drugs in a Patient With Lupus. Cureus. 2023;15(5):e38862.
Zhou J, Ma X, Lu TJ, Zhuang Y, Li JL, Chen H. Epidemiological characteristics of pulmonary tuberculosis among students in Guizhou, China: a retrospective study from 2010 to 2020. BMJ Open. 2023;13(5):e072010.
Bohlbro AS, Mendes AM, Sifna A, et al. BCG is protective against death in male but not female patients with pulmonary tuberculosis in Guinea-Bissau. Trans R Soc Trop Med Hyg. 2023;117(5):365-374.
Gunasekera KS, Marcy O, Muñoz J, et al. Development of treatment-decision algorithms for children evaluated for pulmonary tuberculosis: an individual participant data meta-analysis. Lancet Child Adolesc Health. 2023;7(5):336-346.
Chen J, Marusinec R, Brown R, Shiau R, Jaganath D, Chitnis AS. Epidemiology of Culture-Negative Pulmonary Tuberculosis-Alameda County, 2010-2019. J Public Health Manag Pract. 2023;29(3):353-360.
Sossen B, Richards AS, Heinsohn T, et al. The natural history of untreated pulmonary tuberculosis in adults: a systematic review and meta-analysis. Lancet Respir Med. 2023;11(4):367-379.
Sinha S, Thukral H, Shareef I, et al. Prevention of relapse in drug sensitive pulmonary tuberculosis patients with and without vitamin D3 supplementation: A double blinded randomized control clinical trial. PLoS One. 2023;18(3):e0272682.
Fu L, Wang L, Wang H, et al. A cross-sectional study: a breathomics based pulmonary tuberculosis detection method. BMC Infect Dis. 2023;23(1):148.
Varughese M, Heffernan C, Li MY, Long R. Time to diagnosis and treatment of pulmonary tuberculosis in indigenous peoples: a systematic review. BMC Infect Dis. 2023;23(1):131.
Zhan M, Xue H, Wang Y, et al. A clinical indicator-based prognostic model predicting treatment outcomes of pulmonary tuberculosis: a prospective cohort study. BMC Infect Dis. 2023;23(1):101.
Lin EC, Tu HP, Hong CH. Limited effect of reducing pulmonary tuberculosis incidence amid mandatory facial masking for COVID-19. Respir Res. 2023;24(1):54.
Ge Q, Ma Y, Zhang L, et al. Effect of a modified regimen on drug-sensitive retreated pulmonary tuberculosis: A multicenter study in China. Front Public Health. 2023; 11:1039399.
Kanjanaphan T. Contact investigation in healthcare personnel exposed to ped
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Anjima Shaji L., Kumanan R., Sudha S., Yashid Mohammed T., Manasa P., Avanthika M., Aziya Nizam B.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
10.55544/jrasb
editor@jrasb.com or mailtojrasb@gmail.com | 
+91-8874396939
This work is licensed under a 